Implications of gender differences for human health risk assessment and toxicology

Environmental Research

Volumn 104, Issue 1, 2007, Pages 70-84

  Vahter, Marie ^a   Gochfeld, Michael ^b   Casati, Barbara ^c   Thiruchelvam, Mona ^b   Falk Filippson, Agneta ^d   Kavlock, Robert ^e   Marafante, Erminio ^c   Cory Slechta, Deborah ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RUTGERS UNIVERSITY   (United States)

^c JOINT RESEARCH CENTRE   (Italy)

^d Swedish Chemicals Agency   (Sweden)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Gender; Gene expression; Sex difference in toxicodynamics; Sex difference in toxicokinetics; Sex dimorphism; Sex hormones

Indexed keywords

SEX HORMONE;

EPIDEMIOLOGY; GENDER RELATIONS; HEALTH RISK; HEALTH WORKER; RISK ASSESSMENT; SEX HORMONE; SEX-RELATED DIFFERENCE; TOXICOLOGY;

ARTICLE; DEVELOPMENTAL STAGE; DYNAMICS; EMBRYO DEVELOPMENT; EXPOSURE; FEMALE; GAMETE; GENDER; GENE EXPRESSION REGULATION; GENITAL SYSTEM; HUMAN; LIFE CYCLE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

BONE AND BONES; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC METHODS; FEMALE; GENE EXPRESSION REGULATION; HAZARDOUS SUBSTANCES; HEALTH STATUS; HUMANS; KIDNEY; MALE; PHARMACOKINETICS; REPRODUCTION; RISK ASSESSMENT; SEX CHARACTERISTICS; TOXICOLOGY;

ANIMALIA;

EID: 34147199923     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2006.10.001     Document Type: Article

References (142)

1. Aichhom W., Whitworth A.B., Weiss E.M., and Marksteiner J. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?. Drug Safety 29 (2006) 587-598
2. Åkesson A., Berglund M., Schutz A., Bjellerup P., Bremme K., and Vahter M. Cadmium exposure in pregnancy and lactation in relation to iron status. Am. J. Public Health 92 (2002) 284-287
3. Akesson A., Bjellerup P., Lundh T., Lidfeldt J., Nerbrand C., Samsioe G., Skerfving S., and Vahter M. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect. 114 6 (2006) 830-834
4. Akesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., Nerbrand C., Samsioe G., Stromberg U., and Skerfving S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect. 113 11 (2005) 1627-1631
5. Bæcklund M., Pedersen N.L., Björkman L., and Vahter M. Variation in blood concentrations of cadmium and lead in the elderly. Environ. Res. A80 (1999) 222-230
6. Baetjer A. Women in Industry: Their Health and Efficiency (1946), National Research Council, Washington, DC
7. Batchelor J.R., Welsh K.I., Tinoco R.M., Dollery C.T., Hughes G.R.V., Bernstein R., Ryan P., Naish P.F., Aber G.M., Bing R.F., and Russell G.I. Hydralazine induced systemic lupus erythematosis: influence of HLA-DR and sex on susceptibility. Lancet 1 (1980) 1107-1109
8. Bendersky M., Bennett D., and Lewis M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J. Pediatr. Psychol. 31 (2006) 71-84
9. Berglund M., Lind B., Lannero E., and Vahter M. A pilot study of lead and cadmium exposure in young children in Stockholm, Sweden: methodological considerations using capillary blood microsampling. Arch. Environ. Contam. Toxicol. 27 (1994) 281-287
10. Brown-Grant K., Fink G., Greig F., and Murray M.A.F. Altered sex development in male rats after estrogen administration during the neonatal period. J. Reprod. Fertil. 44 (1975) 25-42
11. Buchet J.P., Heilier J.F., Bernard A., Lison D., Jin T., Wu X., Kong Q., and Nordberg G. Urinary protein excretion in humans exposed to arsenic and cadmium. Int. Arch. Occup. Environ. Health 76 (2003) 111-120
12. Burger J., and Gochfeld M. Gender differences in smoking behavior in a university workplace. Sex Roles 20 (1989) 523-533
13. Calabrese E.J. Toxic susceptibility: male-female differences (1985), Wiley, New York
14. Cheng, X., Maher, J.M., Lu, H., Klaassen, C.D., 2006. Endocrine regulation of gender-divergent mouse organic anion transporting polypeptide (Oatp) expression. Mol. Pharmacol. June 28 [Epub. ahead of print].
15. Clark H.A., and Snedeker S.M. Critical evaluation of the cancer risk of dibromochloropropane (DBCP). J. Environ. Sci. Health C 23 2 (2005) 215-260
16. Clark A.F., Marcellus S., deLory B., and Bird C.E. Plasma testosterone free index: a better indicator of plasma androgen activity?. Fertil Steril 26 10 (1975) 1001-1005
17. Clodfelter, K.H., Holloway, M.G., Hodor, P., Park, S.H., Ray, W.J., Waxman, D.J., 2006. Sex-dependent liver gene expression is extensive and largely dependent upon STAT5b: STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol. Endocrinol. February 9 [Epub. ahead of print].
18. Colon I., Caro D., Bourdony C.J., and Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ. Health Perspect. 108 (2000) 895-900
19. Concha G., Vogler G., Nermell B., and Vahter M. Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in drinking water. Int. Arch. Environ. Health 71 (1998) 42-46
20. Corley R.A., Grant D.M., Farris E., Weitz K.K., Soelberg J.J., Thrall K.D., and Poet T.S. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling. Toxicol. Lett. 156 (2005) 127-161
21. Cory-Slechta D.A., Thiruchelvam M., Barlow B.K., and Richfield E.K. Developmental pesticide models of the Parkinson disease phenotype. Environ. Health Perspect. 113 (2005) 1263-1270
22. Cummings A.M., and Kavlock R.J. Function of sexual glands and mechanism of sex differentiation. J. Toxicol. Sci. 29 (2004) 167-178
23. Cumming A.M., Stoker T., and Kavlock R. Gender-based differences in endocrine and reproductive toxicology. Environ. Res. 104 1 (2007) 96-107
24. Dalen J.E. Aspirin to prevent heart attack and stroke: what's the right dose?. Am. J. Med. 2119 (2006) 198-202
25. Daniel J.W., and Gage J.C. The absorption and excretion of butylated hydroxytoluene (BHT) in the rat. Food Cosmet. Toxicol. 3 (1965) 405-415
26. Dewing P., Chiang C.W., Sinchak K., Sim H., Fernagut P.O., Kelly S., Chesselet M.F., Micevych P.E., Albrecht K.H., Harley V.R., and Vilain E. Direct regulation of adult brain function by the male-specific factor SRY. Curr. Biol. 16 (2006) 415-420
27. Dill J.A., Fuciarelli A.F., Lee K.M., Mellinger K.M., Chan P.C., Burka L.T., and Roycroft J.H. Single administration toxicokinetic studies of decalin (decahydronaphthalene) in rats and mice. Toxicol. Sci. 72 (2003) 210-222
28. Dubb A., Gur R., Avants B., and Gee J. Characterization of sexual dimorphism in the human corpus callosum. Neuroimage 20 (2003) 512-519
29. Environmental Protection Agency, 1988. Recommendations for and documentation of biological values for use in risk assessment. PB-179874; EPA 600/6-87/008, US Environmental Protection Agency, Cincinnati, OH.
30. Ernstgård L., Sjogren B., Warholm M., and Johanson G. Sex differences in the toxicokinetics of inhaled solvent vaporsin humans 1. m-Xylene. Toxicol. Appl. Pharmacol. 1 (2003) 147-157
31. Ernstgård L., Sjogren B., Warholm M., and Johanson G. Sex differences in the toxicokinetics of inhaled solvent vapors in humans 2. 2-propanol. Toxicol. Appl. Pharmacol. 1 (2003) 158-167
32. Falk-Filippson A., Hanberg A., Victorin K., Warholm M., and Wallin M. Assessment factors: applications in health risk assessment of chemicals. Environ. Res. 104 1 (2007) 108-127
33. Falls J.G., Blake B.L., Cao Y., Levi P.E., and Hodgson E. Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice. J. Biochem. Toxicol. 10 (1995) 171-177
34. Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice. Fed. Register 58 (1993) 39406-39416
35. Freeman N.C., Hore P., Black K., Jimenez M., Sheldon L., Tulve N., and Lioy P.J. Contributions of children's activities to pesticide hand loadings following residential pesticide application. J. Expo. Anal. Environ. Epidemiol. 15 (2005) 81-88
36. Fukuda M., Fukuda K., Shimizu T., and Moller H. Decline in sex ratio at birth after Kobe earthquake. Hum. Reprod. 13 (1998) 2321-2322
37. Fukuda M., Fukuda K., Shimizu T., Andersen C.Y., and Byskov A.G. Parental periconceptional smoking and male:female ratio of newborn infants. Lancet 20 (2002) 1407-1408
38. Giedd J.N., Castellanos F.X., Rajapakse J.C., Vaituzis A.C., and Rapoport J.L. Sexual dimorphism of the developing human brain. Prog. Neuropsychopharmacol. Biol. Psychiat. 21 (1997) 1185-1201
39. Gimenez-Llort L., Ahlbom E., Dare E., Vahter M., Ogren S., and Ceccatelli S. Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. Environ. Toxicol. Pharmacol. 9 3 (2001) 61-70
40. Gleiter C.H., and Gundert-Remy U. Gender differences in pharmacokinetics. Eur. J. Drug Metab. Pharmacokinet. 21 (1996) 123-128
41. Gochfeld M. Framework for gender differences in human and animal toxicology. Environ. Res. 104 1 (2007) 4-21
42. Goldstein J.M., Seidman L.J., Horton N.J., Makris N., Kennedy D.N., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb. Cortex 11 (2001) 490-497
43. Goldstein B.D., Klein W., and Suk W. SGOMSEC 15-methodologies for assessing exposure to metals: speciation, bioaccessibility, and bioavailability in the environment, food and feed. Ecotoxicol. Environ. Safety 56 (2003) 3-5 (and subsequent papers)
44. Goodrich J.A., and Hottendorf G.H. Tobramycin gender-related nephrotoxicity in Fischer but not Sprague-Dawley rats. Tox. Lett. 75 (1995) 127-131
45. Gotoh Y., Kato Y., Stieger B., Meier P.J., and Sugiyama Y. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-d-glucuronide in rats. Am. J. Physiol. Endocrinol. Metab. 282 (2002) 1245-1254
46. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., Murata K., Sorensen N., Dahl R., and Jorgensen P.J. Cognitive deficit in 7-year old children with prenatal exposure to methyl-mercury. Neurotoxicol. Teratol. 20 (1997) 417-428
47. Grandjean P., Weihe P., White R.F., and Debes F. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ. Res. 77 (1998) 165-172
48. Guillette Jr. L.J., Crain D.A., Rooney A.A., and Pickford D.B. Organization versus activation: the role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife. Environ. Health Perspect. 103 Suppl 7 (1995) 157-164
49. Gulson B.L., Mahaffey K.R., Mizon K.J., Korsch M.J., Cameron M.A., and Vimpani G. Contribution of tissue lead to blood lead in adult female subjects based on stable lead isotope methods. J. Lab. Clin. Med. 125 (1995) 703-712
50. Gulson B.L., Mizon K.J., Korsch M.J., Palmer J.M., and Donnelly J.B. Mobilization of lead from human bone tissue during pregnancy and lactation-a summary of long-term research. Sci. Total Environ. 303 (2003) 79-104
51. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 31 (1997) 482-488
52. Guo Z., Wang M., Tian G., Burger J., Gochfeld M., and Yang C.S. Age- and genderrelated variations in the activities of drug-metabolizing and antioxidant enzymes in the Whitefooted Mouse (Peromyscus leucopus). Growth Dev. Aging 57 (1993) 85-100
53. Harber M.H., and Jennings R.B. Sex differences in renal toxicity of mercury in the rat. Nature 201 (1964) 1235
54. Harber M.N., and Jenning R.B. Renal response of the ratto mercury, the effect of sex and sex hormones. Arch. Pathol. 79 (1965) 218-222
55. Harris R.Z., Benet L.Z., and Schwartz J.B. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50 (1995) 222-239
56. Hart L.G., and Adamson R.H. Effect of Phenobarbital on biliary excretion of organic acids in male and female rats. Am. J. Physiol. 217 (1968) 46-52
57. Haywood S., Dincer Z., Jasani B., and Loughran M.J. Molybdenum-associated pituitary endocrinopathy in sheep treated with ammonium tetrathiomolybdate. J. Comp. Pathol. 130 (2004) 21-31
58. Hellström L., Elinder C.G., Dahlberg B., Lundberg M., Järup L., Persson B., and Axelson O. Cadmium exposure and end-stage renal disease. Am. J. Kidney Dis. 38 (2001) 1001-1008
59. Hernandez-Avila M., Villalpando C.G., Palazuelos E., Hu H., Villalpando M.E., and Martinez D.R. Determinants of blood lead levels across the menopausal transition. Arch. Environ. Health 55 (2000) 355-360
60. Hines M., Brook C., and Conway G.S. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J. Sex Res. 1 (2004) 75-81
61. Hopenhayn C., Huang B., Christian J., Peralta C., Ferreccio C., Atallah R., and Kalman D. Profile of urinary arsenic metabolites during pregnancy. Environ. Health Perspect. 111 (2003) 1888-1891
62. Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Moore L.E., and Smith A.H. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 104 (1996) 1200-1207
63. Hsia D.Y., Dowben R.M., and Shaw R. Inhibition of glucuronosyl transferase by progestgational agents from serum of pregnant women. Nature 187 (1960) 693-694
64. Hsia D.Y., Riabov S., and Dowben R.M. Inhibition of glucuronosyl transferase by steroid hormones. Arch. Biochem. Biophys. 103 (1963) 181-185
65. ICRP, 2003. Basic anatomical and physiological data for use in radiological protection, reference values. International Commission on Radiological Protection. ICRP Publ. 89.
66. Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter (2001), National Academy Press, Washington, DC
67. Ivanova T., and Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54 (2003) 638-647
68. Janmohamed A., Hernandez D., Phillips I.R., and Shephard E.A. Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem. Pharmacol. 1 (2004) 73-83
69. Järup L., Berglund M., Elinder C.G., Nordberg G., and Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand. J. Work Environ. Health 24 (1998) 1-52
70. Kaasinen V., Kemppainen N., Nagren K., Helenius H., Kurki T., and Rinne J.O. Age-related loss of extrastriatal dopamine D(2)-like receptors in women. J. Neurochem. 81 (2002) 1005-1010
71. Kelada S.N., Costa-Mallen P., Costa L.G., Smith-Weller T., Franklin G.M., Swanson P.D., Longstreth Jr. W.T., and Checkoway H. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology 23 (2002) 515-519
72. Kjellström T. Mechanism and epidemiology of bone effects of cadmium. IARC Sci. Publ. 118 (1992) 301-310
73. Kobayashi S., Isotani A., Mise N., Yamamoto M., Fujihara Y., Kaseda K., Nakanishi T., Ikawa M., Hamada H., Abe K., and Okabe M. Comparison of gene expression in male and female mouse blastocysts revealed imprinting of the X-linked gene, Rhox5/Pem, at preimplantation stages. Curr. Biol. 16 (2006) 166-172
74. Lehman A.J., and Fitzhugh O.G. 100-fold margin of safety. Assoc. Food Drug Off. US Quart. Bull. 18 (1954) 33-35
75. Lemaitre H., Crivello F., Grassiot B., Alperovitch A., Tzourio C., and Mazoyer B. Age- and sex-related effects on the neuroanatomy of healthy elderly. Neuroimage 26 (2005) 900-911
76. Leng X.H., Hong S.Y., Larrucea S., Zhang W., Li T.T., Lopez J.A., and Bray P.F. Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 376-381
77. Lunde P.K., Frislid K., and Hansteen V. Disease and acetylation polymorphism. Clin. Pharmacokinet. 2 (1977) 182-197
78. Marshall E. Getting the noise out of gene arrays. Science 306 (2004) 630-631
79. Matsuura B., Taniguchi Y., and Ohta Y. Effect of antiandrogen treatment on chemical hepatocarcinogenesis in rats. J Hepatol. 21 2 (1994) 187-193
80. Meding B. Differences between the sexes with regard to work-related skin disease. Contact Dermatitis 43 (2000) 65-71
81. Meibohm B., Beierle I., and Derendorf H. How important are gender differences in pharmacokinetics?. Clin. Pharmacokinet. 41 (2002) 329-342
82. Meistrich M.L., Wilson G., Shuttlesworth G.A., and Porter K.L. Dibromochloropropane inhibits spermatogonial development in rats. Reprod. Toxicol. 17 (2003) 263-271
83. Minami T., Sakita Y., Ichida S., and Dohi Y. Gender difference regarding selenium penetration into the mouse brain. Biol. Trace Elem. Res. 89 (2002) 85-93
84. Miyamoto, J., Burger, J., 2003. SCOPE/IUPAC Symposium on Environmental Implications of Endocrine Active Substances: Present State-of-the-art and Future Research Needs. Pure Appl. Chem. 75.
85. Mocarelli P., Gerthoux P.M., Ferrari E., Patterson Jr. D.G., Kieszak S.M., Brambilla P., Vincoli N., Signorini S., Tramacere P., Carreri V., Sampson E.J., Turner W.E., and Needham L.L. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 355 9218 (2000) 1858-1863
86. Newbold R.R. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 199 (2004) 142-150
87. Nilsson U., Attewell R., Christoffersson J.O., Schutz A., Ahlgren L., Skerfving S., and Mattsson S. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol. Toxicol. 68 (1991) 477-484
88. Olden K., and Newbold R.R. Women's health and the environment in the 21st century. Environ. Health Perspect. 108 (2000) 767-768
89. Oliver T. Dangerous Trades (1902), John Murray Publishers, London
90. Olsson I.M., Bensryd I., Lundh T., Ottosson H., Skerfving S., and Oskarsson A. Cadmium in blood and urine-impact of sex, age, dietary intake, iron status, and former smoking-association of renal effects. Environ. Health Perspect. 110 (2002) 1185-1190
91. Osman K., Schutz A., Akesson B., Maciag A., and Vahter M. Interactions between essential and toxic elements in lead exposed children in Katowice, Poland. Clin. Biochem. 31 (1998) 657-665
92. Ostrer H. Sexual differentiation. Semin. Reprod. Med. 18 (2000) 41-49
93. Pannetier M., Mandon-Pepin B., Copelli S., and Fellous M. Molecular aspects of female and male gonadal development in mammals. Pediatr. Endocrinol. Rev. 1 (2004) 274-287
94. Park K.M., Kim J.I., Ahn Y., Bonventre A.J., and Bonventre J.V. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J. Biol. Chem. 279 (2004) 52282-52292
95. Pedersen A.T., and Ottesen B. Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials-time out for hormone replacement therapy studies?. Hum. Reprod. 18 (2003) 2241-2244
96. Pence D.H., and Schnell R.C. Sex-related differences in the effect of cadmium on the induction of heptatic microsomal monooxygenases by phenobarbitalin male and female rats. Toxicol. Lett. 5 (1980) 333-338
97. Pounds J.G., Long G.J., and Rosen J.F. Cellular and molecular toxicity of lead in bone. Environ. Health Perspect. 91 (1991) 17-32
98. Radimer K., Bindewald B., Hughes J., Ervin B., Swanson C., and Picciano M.F. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am. J. Epidemiol. 15 (2004) 339-349
99. Renwick A.G. Safety factors and establishment of acceptable daily intakes. Food Addit. Contam. 8 (1991) 135-150
100. Renwick A.G. The use of safety or uncertainty factors in the setting of acute reference doses. Food Addit. Contam. 17 (2000) 627-635
101. Rice J.M. The biological behaviour of transplacentally induced tumours in mice. In: Tomatis L., Mohr U., and Davis W. (Eds). Transplacental Carcinogenesis 4 (1973), IARC Sci. Publ., Lyon, France 71-83
102. Ridker P.M., Cook N.R., Lee I.M., Gordon D., Gaziano J.M., Manson J.E., Hennekens C.H., and Buring J.E. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med. 352 (2005) 1293-1304
103. Roberts J.S., and Silbergeld E.K. Pregnancy, lactation, and menopause: how physiology and gender affect the toxicity of chemicals. Mt. Sinai J. Med. 62 (1995) 343-355
104. Roberts R.K., Desmond P.V., Wilkinson G.R., and Schenker S. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin. Pharmacol. Ther. 25 (1979) 826-831
105. Rossi A.D., Ahlbom E., Ogren S.O., Nicotera P., and Ceccatelli S. Prenatal exposure to methylmercury alters locomotor activity of male but not female rats. Exp. Brain Res. 17 (1997) 428-436
106. Routledge P.A., Stargel W.W., Kitchell B.B., Barchowsky A., and Shand D.G. Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br. J. Clin. Pharm. 11 (1981) 245-252
107. Roy A.B. Comparative studies on the liver sulphatases. Biochem. J. 68 (1958) 519-528
108. Sakamoto M., Nakano A., and Akagi H. Declining Minnamata male birth ration associated with increased male fetal death due to heavy methyl mercury pollution. Environ. Res. 87 (2001) 92-98
109. Satarug S., Baker J.R., Reilly P.E., Moore M.R., and Williams D.J. Cadmium levels in the lung, liver, kidney cortex, and urine samples from Australians without occupational exposure to metals. Arch. Environ. Health 57 (2002) 69-77
110. Sato M., Yamanobe K., and Nagai Y. Sex-related differences in cadmium-induced lipid peroxidation in the rat. Life Sci. 33 (1983) 903-908
111. Sayegh R.A., and Stubblefield P.G. Bone metabolism and the perimenopause overview, risk factors, screening, and osteoporosis preventive measures. Obstet. Gynecol. Clin. North Am. 29 (2002) 495-510
112. Scallet A.C., and Meredith J.M. Quantitative three-dimensional reconstruction: feasibility for studies of sexually dimorphic hypothalamic development in rats. Neurotoxicol. Teratol. 24 (2002) 81-85
113. Scallet A.C., Muskhelishvili L., Slikker Jr. W., and Kadlubar F.F. Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon. J. Chem. Neuroanat. 29 (2005) 71-80
114. Schroeder H.A., and Vinton Jr. W.H. Hypertension induced in rats by small doses of cadmium. Am. J. Physiol. 202 (1962) 515-518
115. Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Perspect. 91 (1991) 71-75
116. Schwartz J.B. The influence of sex on pharmacokinetics. Clin. Pharmacokinet. 42 (2003) 107-121
117. Seeman E. Invited review: pathogenesis of osteoporosis. J. Appl. Physiol. 95 5 (2003) 2142-2151
118. SGOMSEC 12. Methodology involved in determining susceptibility to chemical and physical agents in the workplace or general environment. Environ. Health Perspect. 105 (1997)
119. Shalat S.L., Donnelly K.C., Freeman N.C., Calvin J.A., Ramesh S., Jimenez M., Black K., Coutinho C., Needham L.L., Barr D.B., and Ramirez J. Nondietary ingestion of pesticides by children in an agricultural community on the US/Mexico border: preliminary results. J. Expo. Anal. Environ. Epidemiol. 1 (2003) 42-50
120. Silbergeld E.K., and Flaws J.A. Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. J. Women's Health 8 (1999) 227-234
121. Silbergeld E.K., Schwartz J., and Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ. Res. 47 (1988) 79-94
122. Smith J.H., Maita K., Sleight S.D., and Hook J.B. Mechanism of chloroform nephrotoxicity. I. Time course of chloroform toxicity in male and female mice. Toxicol Appl Pharmacol. 70 3 (1983) 467-479
123. Staessen J.A., Vyncke G., Lauwerys R.R., Roels H.A., Celis H.G., Claeys F., Dondeyne F., Fagard R.H., Ide G., and Lijnen P.J. Transfer of cadmium from a sandy acidic soil to man: a population study. Environ. Res. 58 (1992) 25-34
124. Stellman J.M. Women's Work, Women's Health (1977), Pantheon, New York
125. Symanski E., and Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am. J. Epidemiol. 141 (1995) 1047-1058
126. Taaffe D.R., Lang T.F., Fuerst T., Cauley J.A., Nevitt M.C., and Harris T.B. Sex- and race-related differences in cross-sectional geometry and bone density of the femoral mid-shaft in older adults. Ann. Hum. Biol. 30 (2003) 329-346
127. Tanaka E. Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Ther. 24 (1999) 339-346
128. Tanaka T., Naganuma A., Miura N., and Imura N. Role of testosterone in gammaglutamyltranspeptidase-dependent renal methylmercury uptake in mice. Toxicol. Appl. Pharmacol. 112 (1992) 58-63
129. Tannenbaum G.S., Choi H.K., Gurd W., and Waxman D.J. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 142 (2001) 4599-4606
130. Tucker Jr. W.E., Janssen F.W., Agersborg Jr. H.P., Young E.M., and Ruelius H.W. Sex and species-related nephropathy of 6-(1-aminocyclohexanecarboxamido) penicillanic acid (cyclacillin) and its relationship to the metabolic disposition of the drug. Toxicol. Appl. Pharmacol. 29 (1974) 1-18
131. Vahter M., Akesson A., Liden C., Ceccatelli S., and Berglund M. Gender differences in disposition and toxicity of metals. Environ. Res. 104 1 (2007) 85-95
132. Vahter M., Berglund M., Åkesson A., and Liden C. Metals and women's health. Environ. Res. 88 (2002) 145-155
133. Vahter M., Berglund M., and Åkesson A. Toxic metals and the menopause. J. Br. Menopause Soc. 27 10 (2004) 60-64
134. Waalkes M.P., Liu J., Ward J.M., and Diwan B.A. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 20 (2004) 31-38
135. Wang H., Zhu G., Shi Y., Weng S., Jin T., Kong Q., and Nordberg G.F. Influence of environmental cadmium exposure on forearm bone density. J. Bone Miner Res. 18 (2003) 553-560
136. Westerholm B. Clinical toxicology of estrogens. Pharmacol. Ther. 10 (1980) 337-349
137. Wickman S., Kajantie E., and Dunkel L. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. J Clin. Endocrinol. Metab. 88 (2003) 3785-3793
138. Williams G.M. Carcinogenic responses to toxic liver injury in rodents. In: McCuskey R.S., and Earnest D.L. (Eds). Comprehensive Toxicology vol. 9 (1997), Elsevier, New York 165-179
139. Williams S.W., and Blunk E.M. Sex differences in infant-mother attachment. Psychol. Rep. 92 (2003) 84-88
140. Yamanaka O., Kobayashi E., Nogawa K., Suwazono Y., Sakurada I., and Kido T. Association between renal effects and cadmium exposure in cadmium-nonpolluted area in Japan. Environ. Res. 77 (1998) 1-8
141. Zahm S.H., and Fraumeni Jr. J.F. Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ. Health Perspect. 103 (1995) 283-286
142. Zarén B., Lindmark G., and Bakketeig L. Maternal smoking affects fetal growth more in the male fetus. Paediatr. Perinat. Epidemiol. 14 (2000) 118-126